- Home
- SNES
SNES
SenesTech Inc.
as 07-26-2024 4:00pm EST
SenesTech Inc is a United States-based biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control. The company provides its solutions to the animal market, commercial markets, and food markets. It currently has two product lines of fertility control products: ContraPest and Evolve.
| Founded: | 2004 | Country: | United States |
| Employees: | N/A | City: | FLAGSTAFF |
| Market Cap: | 3.0M | IPO Year: | 2016 |
| Target Price: | $3.50 | AVG Volume (30 days): | 13.3K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -22.70 | EPS Growth: | N/A |
| 52 Week Low/High: | $4.00 - $113.64 | Next Earning Date: | 08-08-2024 |
| Revenue: | $1,375,000 | Revenue Growth: | 30.09% |
| Revenue Growth (this year): | 91.45% | Revenue Growth (next year): | 101.31% |
Latest SenesTech Inc. News
SNES Breaking Stock News: Dive into SNES Ticker-Specific Updates for Smart Investing
MT Newswires
3 days ago
SenesTech to Implement 1-for-10 Reverse Split of Common Stock; Shares Fall
PR Newswire
3 days ago
SenesTech Announces Reverse Stock Split
PR Newswire
a month ago
SenesTech's Evolve™ Fertility Control Solution for Rats To Be Deployed in the U.S. Virgin Islands
GlobeNewswire
a month ago
Presenting on the Emerging Growth Conference 72 Day 2 on June 13 Register Now
GlobeNewswire
2 months ago
Presenting on the Emerging Growth Conference 72 Day 1 on June 12 Register Now
GOBankingRates
2 months ago
5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers
AFP
2 months ago
Bumrah delivers as India beat Pakistan in low-scoring thriller
AFP
2 months ago
Italy beat Bosnia in final Euros warm-up
Compare SNES vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "SNES SenesTech Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.